Material Safety Data Sheet Section 1. Identification of the substance 4-Methylcyclohexen-1-ylboronic acid Product Name: Synonyms: 4-Methyl-1-cyclohexen-1-ylboronic acid Section 2. Hazards identification Harmful by inhalation, in contact with skin, and if swallowed. H315: Causes skin irritation H319: Causes serious eye irritation H335: May cause respiratory irritation P261: Avoid breathing dust/fume/gas/mist/vapours/spray Wear protective gloves/protective clothing/eye protection/face protection P280: P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do – continue rinsing P304+P340: IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing P405: Store locked up Section 3. Composition/information on ingredients. 4-Methylcyclohexen-1-ylboronic acid Ingredient name: CAS number: 850567-92-9 Section 4. First aid measures Immediately wash skin with copious amounts of water for at least 15 minutes while removing Skin contact: contaminated clothing and shoes. If irritation persists, seek medical attention. Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical attention. Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention. Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention. Ingestion: Section 5. Fire fighting measures In the event of a fire involving this material, alone or in combination with other materials, use dry powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus should be worn. Section 6. Accidental release measures Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national standards. Respiratory precaution: Wear approved mask/respirator Hand precaution: Wear suitable gloves/gauntlets Skin protection: Wear suitable protective clothing Eye protection: Wear suitable eye protection Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container for disposal. See section 12. Environmental precautions: Do not allow material to enter drains or water courses. Section 7. Handling and storage Handling: This product should be handled only by, or under the close supervision of, those properly qualified in the handling and use of potentially hazardous chemicals, who should take into account the fire, health and chemical hazard data given on this sheet. Store in closed vessels, under −20◦C. Storage: Section 8. Exposure Controls / Personal protection Engineering Controls: Use only in a chemical fume hood. Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles. General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse. Section 9. Physical and chemical properties Not specified Appearance: Boiling point: No data Melting point: No data Flash point: No data Density: No data Molecular formula: C7H13BO2 Molecular weight: 140.0 Section 10. Stability and reactivity Conditions to avoid: Heat, flames and sparks. Materials to avoid: Oxidizing agents. Possible hazardous combustion products: Carbon monoxide. Section 11. Toxicological information No data. Section 12. Ecological information No data. Section 13. Disposal consideration Arrange disposal as special waste, by licensed disposal company, in consultation with local waste disposal authority, in accordance with national and regional regulations. Section 14. Transportation information Non-harzardous for air and ground transportation. Section 15. Regulatory information No chemicals in this material are subject to the reporting requirements of SARA Title III, Section 302, or have known CAS numbers that exceed the threshold reporting levels established by SARA Title III, Section 313.
Palladium-Catalyzed Preparation of Weinreb Amides from Boronic Acids and <i>N</i>-Methyl-<i>N</i>-methoxycarbamoyl Chloride
作者:Ravi Krishnamoorthy、Sang Q. Lam、Christopher M. Manley、R. Jason Herr
DOI:10.1021/jo902647h
日期:2010.2.19
A simple protocol for the synthesis of Weinreb benzamides and α,β-unsaturated Weinrebamides through a palladium-catalyzed cross-coupling reaction between organoboronic acids and N-methoxy-N-methylcarbamoyl chloride has been developed. The method is also applicable to the use of potassium organotrifluoroborates.
Synthesis of α-oxygenated ketones and substituted catechols via the rearrangement of N-enoxy- and N-aryloxyphthalimides
作者:Michelle A. Kroc、Aditi Patil、Anthony Carlos、Josiah Ballantine、Stephanie Aguilar、Dong-Liang Mo、Heng-Yen Wang、Daniel S. Mueller、Donald J. Wink、Laura L. Anderson
DOI:10.1016/j.tet.2017.01.061
日期:2017.7
synthesis of α-oxygenated carbonylcompounds and catechols is the treatment of a carbonylcompound or a phenol with an electrophilic oxygen source. As an alternative approach to these important structures, formal [3,3]-rearrangements of N-enoxyphthalimides, N-enoxyisoindolinones, and N-aryloxyphthalimides have been explored. When used in combination with an initial Chan-Lam coupling, these transformations
A series of 2-alkyl/alkenyl pyridine C-region derivatives of 2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides were investigated as hTRPV1 antagonists. Multiple compounds showed excellent and stereospecific TRPV1 antagonism with better potency than previous lead 2. Among them, compound 15f demonstrated a strong analgesic profile in a rat neuropathic pain model and blocked capsaicin-induced hypothermia
An efficient asymmetric hydrogenation of cyclic tetrasubstituted-olefinic dehydroamino acidderivatives has been achieved with a Rh-ArcPhos catalyst, affording a series of α-acylamino-β-alkyl tetrahydropyranones with two contiguous chiral centers in up to 96% ee and 1000 TON.
使用 Rh-ArcPhos 催化剂实现了环状四取代烯烃脱氢氨基酸衍生物的有效不对称氢化,得到了一系列具有两个连续手性中心的 α-酰基氨基-β-烷基四氢吡喃酮,其 ee 和 1000 TON。
Isothiazole derivatives as GPR120 agonists for the treatment of type II diabetes
申请人:Janssen Pharmaceutica NV
公开号:US09067898B1
公开(公告)日:2015-06-30
Disclosed are compounds, compositions and methods for treating of disorders that are affected by the modulation of the GPR120 receptor. Such compounds are represented by Formula (I) as follows:
wherein R1, G, and Q are defined herein.